Basal and post-methionine serum homocysteine and lipoprotein abnormalities in patients with primary biliary cirrhosis.

被引：0
|
作者：
Ben-Ari, Z
Baruch, Y
Tur-Kaspa, R
Fainaru, M
机构：
[1] Rabin Med Ctr, Liver Inst, Petah Tiqwa, Israel
[2] Rambam Hosp, Dept Med B, Haifa, Israel
[3] Rabin Med Ctr, Dept Med A, Petah Tiqwa, Israel
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1257
引用
收藏
页码：475A / 475A
页数：1
相关论文
共 50 条
  • [1] Basal and post-methionine serum homocysteine and lipoprotein abnormalities in patients with chronic liver disease
    Ben-Ari, Z
    Tur-Kaspa, R
    Schafer, Z
    Baruch, Y
    Sulkes, J
    Atzmon, O
    Greenberg, A
    Levi, N
    Fainaru, M
    JOURNAL OF INVESTIGATIVE MEDICINE, 2001, 49 (04) : 325 - 329
  • [2] Relevance of post-methionine homocysteine and lipoprotein (a) in evaluating the cardiovascular risk in young CAD patients
    Marcucci, R
    Brunelli, T
    Fedi, S
    Pepe, G
    Giusti, B
    Gori, AM
    Prisco, D
    Falai, M
    Margheri, M
    Abbate, R
    Gensini, GF
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (01) : 1 - 7
  • [3] Fasting and post-methionine homocysteine levels in patients with NIDDM.
    Smulders, Y
    Rakic, M
    Treskes, M
    Slaats, E
    Stehouwer, C
    Silberbusch, J
    DIABETES, 1997, 46 : 1148 - 1148
  • [4] LIPOPROTEIN ABNORMALITIES IN PATIENTS WITH EARLY PRIMARY BILIARY-CIRRHOSIS
    ALY, A
    CARLSON, K
    JOHANSSON, C
    KIRSTEIN, P
    ROSSNER, S
    WALLENTIN, L
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1984, 14 (02) : 155 - 162
  • [5] Abnormalities of serum apo A1 containing lipoprotein particles in patients with primary biliary cirrhosis
    OKane, MJ
    Lynch, PLM
    Callender, ME
    Trimble, ER
    ATHEROSCLEROSIS, 1997, 131 (02) : 203 - 210
  • [6] Fracture risk of patients with primary biliary cirrhosis.
    Boulton-Jones, JR
    Fenn, R
    West, J
    Logan, R
    Ryder, S
    HEPATOLOGY, 2001, 34 (04) : 525A - 525A
  • [7] Fenofibrate for patients with asymptomatic primary biliary cirrhosis.
    Dohmen, K
    Mizuta, T
    Nakamuta, M
    Shimohashi, N
    Ishibashi, H
    Yamamoto, K
    HEPATOLOGY, 2003, 38 (04) : 518A - 518A
  • [8] The effect of bezafibrate in patients with primary biliary cirrhosis.
    Nakai, S
    Masaki, T
    Morita, T
    Deguchi, A
    Nishioka, M
    HEPATOLOGY, 1999, 30 (04) : 566A - 566A
  • [9] Bone loss in patients with primary biliary cirrhosis.
    Watane, AA
    Levis, S
    Jeffers, LJ
    Reddy, KR
    Molina, E
    Schiff, ER
    GASTROENTEROLOGY, 1997, 112 (04) : A1413 - A1413
  • [10] Quality of life in patients with primary biliary cirrhosis.
    Bonnand, AM
    Chazouillères, O
    Poupon, RE
    HEPATOLOGY, 1999, 30 (04) : 473A - 473A
12345